Crimson Investment is an international private equity firm that provides buyout and growth capital financing to middle-market companies in the industrial, manufacturing, healthcare, and consumer industries. Crimson typically invests in companies with annual EBITDA of $5 million to $50 million. Crimson has a conservative approach to the use of leverage in its transactions, and believes that the majority of the value creation should be derived from the firm's established globalization strategies and operational improvements.